Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bateman

Showing results (161-170 of 533) with videos related to

Pageof 54
Sort By:
Journal of Neurochemistry|December 29, 2025
Post-Translational Modifications Distinguish Amyloid-β Isoforms in Cerebral Amyloid Angiopathy and Alzheimer's DiseaseSrinivas Koutarapu, Kaleigh F Roberts, Reid A Coyle, et al.
Journal of Alzheimer'S Disease : JAD|November 22, 2021
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are HyperphosphorylatedNicolas R Barthélemy, Balazs Toth, Paul T Manser, et al.
International Journal of Molecular Sciences|August 27, 2020
Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to PhenotypeHuifangjie Li, William C Knight, Pengfei Yang, et al.
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other TauopathiesT West, Y Hu, P B Verghese, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2022
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer diseaseJohannes Levin, Jonathan Vöglein, Yakeel T Quiroz, et al.
Clinical Pediatrics|June 3, 2024
ECHO Autism Washington: Autism Diagnostic Evaluations in Primary CareJennifer Gerdts, Karís A Casagrande, Katherine J Bateman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 13, 2020
Cross-Sectional and Longitudinal Associations Between Plasma Neurodegenerative Biomarkers and Physical Performance Among Community-Dwelling Older AdultsLingxiao He, Philipe de Souto Barreto, Kelly V Giudici, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2022
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performanceAlexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, et al.
Alzheimer'S Research & Therapy|December 21, 2022
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept studyEric McDade, Jeffrey L Cummings, Shobha Dhadda, et al.
Neuroscience Letters|August 3, 2017
A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and ParkinsonismJohn M Ringman, Maria Casado, Victoria Van Berlo, et al.
Pageof 54

Showing results (161-170 of 533) with videos related to

Sort By:
Pageof 54
Journal of Neurochemistry|December 29, 2025
Post-Translational Modifications Distinguish Amyloid-β Isoforms in Cerebral Amyloid Angiopathy and Alzheimer's DiseaseSrinivas Koutarapu, Kaleigh F Roberts, Reid A Coyle, et al.
Journal of Alzheimer'S Disease : JAD|November 22, 2021
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are HyperphosphorylatedNicolas R Barthélemy, Balazs Toth, Paul T Manser, et al.
International Journal of Molecular Sciences|August 27, 2020
Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to PhenotypeHuifangjie Li, William C Knight, Pengfei Yang, et al.
The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other TauopathiesT West, Y Hu, P B Verghese, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2022
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer diseaseJohannes Levin, Jonathan Vöglein, Yakeel T Quiroz, et al.
Clinical Pediatrics|June 3, 2024
ECHO Autism Washington: Autism Diagnostic Evaluations in Primary CareJennifer Gerdts, Karís A Casagrande, Katherine J Bateman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 13, 2020
Cross-Sectional and Longitudinal Associations Between Plasma Neurodegenerative Biomarkers and Physical Performance Among Community-Dwelling Older AdultsLingxiao He, Philipe de Souto Barreto, Kelly V Giudici, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2022
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performanceAlexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, et al.
Alzheimer'S Research & Therapy|December 21, 2022
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept studyEric McDade, Jeffrey L Cummings, Shobha Dhadda, et al.
Neuroscience Letters|August 3, 2017
A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and ParkinsonismJohn M Ringman, Maria Casado, Victoria Van Berlo, et al.
Pageof 54